Marie-Noel Lepage, Manager in Assay Development, shares her extensive experience and passion for Virology and lab work. With a background in Cellular Molecular Biology from Concordia University and over 20 years in the CRO world, Marie-Noel has played a crucial role in preclinical and clinical testing, specializing in Neutralization Assays and Vaccine Development. She discusses her career journey, the impact of her work in drug and vaccine development, and the specific processes involved in creating and validating tests, including significant contributions during the COVID-19 pandemic.
Related Insights
How COVID-19 Changed Clinical Trial Dynamics and Environment
Precision Medicine World Conference 2021 Virtual Presentation
Vaccine Laboratory Services
Test Menu
SARS-CoV-2 Vaccine Induced Antibody Profiles
Presented at World Vaccine Congress 2021
Vaccine Testing for SARS-CoV-2
ELISA and Viral Neutralization Assays
Keeping Up with the Flu: Advances in seasonal influenza vaccine development
Vaccine Laboratory Services
Combating Emerging and Re-Emerging Infectious Diseases in Clinical Trials by Harnessing Innovative Technologies
Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases
Tools for better management of infectious disease clinical trials
Zika Vaccine Research: Complex Steps Toward a Critical Need
Overcoming Zika vaccine development challenges
Vaccine Testing Capabilities
End-to-end laboratory for clinical vaccine development
